z-logo
open-access-imgOpen Access
Hepatoxicity associated with weight-loss supplements: A case for better post-marketing surveillance
Author(s) -
Ano Lobb
Publication year - 2009
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.15.1786
Subject(s) - harm , adverse effect , postmarketing surveillance , kava , weight loss , dietary supplement , medicine , business , marketing , environmental health , pharmacology , food science , biology , political science , obesity , law
There is a growing number of case reports of hepatoxicity from the widely marketed weight-loss supplement Hydroxycut, which contains the botanical ingredient Garcinia cambogia. These case reports may substantially undercount the true magnitude of harm. Based on the past experience with harmful dietary supplements, US regulators should assume the more precautionary approach favored by Canada and Europe. Lacking effective adverse event surveillance for supplements, or the requirements to prove safety prior to coming to the market, case reports such as those summarized here assume added importance.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here